Robert Kent has an extensive background in clinical development and project management, currently serving as the Director of Clinical Development at Eli Lilly and Company since 2025. Previously, Robert held several leadership roles at Eli Lilly, including Manager of Clinical Trial Project Management and Associate Director Clinical Development Trial Lead from 2021 to 2022. Prior experience includes serving as Science Director at AnaBio Technologies Ltd. from 2017 to 2021 and as a Research Assistant at Waterford Institute of Technology in 2013. Robert earned a Bachelor of Science and a PhD in Microbiology from University College Cork, completing the latter in 2014.
This person is not in the org chart
This person is not in any teams
This person is not in any offices